Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 3/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24739206 | 0.98 | PRKDC (0.32) | PRKDCPIM1CSNK2A2CSNK2BPIM3 | |
| SCHEMBL24740192 | 0.95 | MAPT (0.32) | PRKDCPIM1CSNK2A2CSNK2BPIM3 | |
| SCHEMBL24738681 | 0.95 | MAPT (0.32) | PRKDCPIM1CSNK2A2CSNK2BPIM3 | |
| SCHEMBL24738661 | 0.94 | PRKDC (0.32) | PRKDCPIM1CSNK2A2CSNK2BPIM3 | |
| SCHEMBL24738682 | 0.94 | MAPT (0.33) | TSHRHCRTR1 | |
| SCHEMBL25459317 | 0.94 | PRKDC (0.34) | PRKDCPIM1CSNK2A2CSNK2BPIM3 | |
| SCHEMBL24738679 | 0.93 | PIM1 (0.32) | PRKDCPIM1CSNK2A2CSNK2BPIM3 | |
| SCHEMBL24738382 | 0.93 | PRKDC (0.34) | PRKDCTSHR | |
| SCHEMBL24738659 | 0.93 | PRKDC (0.36) | PRKDCTSHRHCRTR1 | |
| SCHEMBL24738355 | 0.93 | PRKDC (0.34) | PRKDCTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220396568-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396568-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, CYP1B1, CRY1 | PRKDC 4383/4885PIM1 1315/4885CSNK2A2 2460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.